Bolna AS maintains a concentrated portfolio of resilient listed companies, chosen for structural quality, disciplined capital allocation, and durable business models. The strategy focuses on long-term capital growth through a balance of stability, innovation, and sector strength. It also owns a small biopharmaceutical subsidiary that invests in emerging ventures.
Wholly owned subsidiary
Updated 2025-06-13